Japan's Sawai Pharmaceutical to buy U.S.'s Upsher-Smith Laboratories for $1.05 bln

SAWAI group

20/04/2017 07:50

TOKYO, April 20 (Reuters) - Japan's Sawai Pharmaceutical Co 
Ltd  4555.T  said on Thursday it would buy U.S. generic drug 
maker Upsher-Smith Laboratories Inc for $1.05 billion in its 
first overseas acquisition.  
    Sawai, an Osaka-based generic drug maker, said it would buy 
the company from the founding family to expand its presence in 
the United States, the world's largest drug market. 
    Sawai plans to complete the deal by the end of June. The 
acquisition will not affect its earnings forecast for the year 
ended March, Sawai said. 
 
 (Reporting by Chris Gallagher and Junko Fujita) 
 ((chris.gallagher@thomsonreuters.com;)) 
 
Keywords: UPSHERSMITH M&A/SAWAI PHARM